First-line (1L) treatment patterns in advanced non-small cell lung cancer (NSCLC) patients (pts) who are elderly or have compromised performance status (PS).

Julia Judd(Palmetto Hematology Oncology), Martin Joseph Edelman(Fox Chase Cancer Center), Elizabeth A. Handorf(Fox Chase Cancer Center), Brinda Gupta(Georgetown University)
Journal of Clinical Oncology
June 1, 2022
Cited by 0


Related Papers